These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11400938)

  • 21. Prospective evaluation of prenatal maternal serum screening for trisomy 18.
    Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT
    Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second-trimester genetic sonography after first-trimester combined screening for trisomy 21.
    Wax JR; Pinette MG; Cartin A; Blackstone J
    J Ultrasound Med; 2009 Mar; 28(3):321-5. PubMed ID: 19244068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
    Lostchuck E; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.
    Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
    Sharda S; Phadke SR
    J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of the genetic sonogram in a stepwise sequential protocol for down syndrome screening.
    Shamshirsaz AA; Ravangard SF; Turner G; Borgida A; Janicki MB; Campbell WA; Zelop C; Shamshirsaz AA; Spiel M; Prabulos AM; Feldman D; Rodis J; Ingardia CJ; Gurram P; Fuller K; Fang YM; Benn P; Egan JF
    J Ultrasound Med; 2013 Sep; 32(9):1607-13. PubMed ID: 23980222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is routine amniocentesis for advanced maternal age still indicated?
    Dommergues M; Audibert F; Benattar C; Champagne C; Gomel V; Frydman R
    Fetal Diagn Ther; 2001; 16(6):372-7. PubMed ID: 11694741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What are the real purpose and scope of screening for aneuploidy?].
    Quibel T; Rozenberg P
    Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The advantages of using triple-marker screening for chromosomal abnormalities.
    Kellner LH; Weiss RR; Weiner Z; Neuer M; Martin GM; Schulman H; Lipper S
    Am J Obstet Gynecol; 1995 Mar; 172(3):831-6. PubMed ID: 7534448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Performance of different methods of estimating risk screening for chromosomal anomalies].
    Avătăjitei MC; Moscalu M; Martiniuc V; Onofriescu M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):515-22. PubMed ID: 23077946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
    Bahado-Singh R; Shahabi S; Karaca M; Mahoney MJ; Cole L; Oz UA
    Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasonographically adjusted midtrimester risk of trisomy 21 and significant chromosomal defects in advanced maternal age.
    Bahado-Singh RO; Deren O; Tan A; D'Ancona RL; Hunter D; Copel JA; Mahoney MJ
    Am J Obstet Gynecol; 1996 Dec; 175(6):1563-8. PubMed ID: 8987942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
    Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
    Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic sonography: a cost-effective method for evaluating women 35 years and older who decline genetic amniocentesis.
    DeVore GR; Romero R
    J Ultrasound Med; 2002 Jan; 21(1):5-13. PubMed ID: 11794403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of second-trimester genetic sonography after Down syndrome screening.
    Aagaard-Tillery KM; Malone FD; Nyberg DA; Porter TF; Cuckle HS; Fuchs K; Sullivan L; Comstock CH; Saade GR; Eddleman K; Gross S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2009 Dec; 114(6):1189-1196. PubMed ID: 19935018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.